1. Home
  2. INTZ vs KTTA Comparison

INTZ vs KTTA Comparison

Compare INTZ & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$0.95

Market Cap

15.7M

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.51

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTZ
KTTA
Founded
1983
2020
Country
United States
United States
Employees
N/A
5
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
18.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
INTZ
KTTA
Price
$0.95
$0.51
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.75
$3.00
AVG Volume (30 Days)
141.2K
323.6K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
71.78
N/A
EPS
N/A
N/A
Revenue
$7,015,000.00
N/A
Revenue This Year
$25.34
N/A
Revenue Next Year
$14.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.56
N/A
52 Week Low
$0.66
$0.28
52 Week High
$2.64
$2.06

Technical Indicators

Market Signals
Indicator
INTZ
KTTA
Relative Strength Index (RSI) 62.34 33.88
Support Level $0.72 $0.51
Resistance Level $1.17 $0.80
Average True Range (ATR) 0.07 0.06
MACD 0.01 0.00
Stochastic Oscillator 59.25 35.26

Price Performance

Historical Comparison
INTZ
KTTA

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: